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1. General introduction 
 
The cell cycle regulatory system is based upon cyclin dependent protein kinases 
(Cdks). The activity of these kinases oscillates during cell cycle progress leading to 
phosphorilation of the cell cycle regulating proteins. This activity is regulated by several 
enzymes and proteins, most importantly by cyclins.  
D type cyclins are one key components of the cell cycle machinery. Three D-cyclins - 
cyclin D1, D2 and D3 - operate in mammalian cells and play a major role in the positive 
regulation of G1 progression. Enforced overexpression of D type cyclins can shorten the G1 
interval in cultured cells. Following mitogen stimulation of quiescent cells, genes encoding D 
type cyclins get activated at the beginning of the G1 phase, and then the produced D type 
cyclins bind to Cdk4 or Cdk6 to activate their kinase activity. Microinjected antibodies or 
antisense constructs directed against D type cyclins can interfere with G1 phase progression, 
without affecting other cell cycle intervals. 
These three proteins are encoded by separate genes located on different chromosomes, 
but they show significant amino acid similarities, suggesting that they arose from a common 
primordial ancestor gene. In the developing skin of mice, cyclin D1 is present in keratinocytes 
and is absent from developing hair follicles, while cyclin D2 exhibits an opposite pattern of 
expression. In mice, cyclin D1 localizes to the proliferative layers in stratified squamous 
epithelia and in columnar gastrointestinal epithelium, whereas cyclin D3 is present in the 
adjacent compartments where differentiation takes place. 
 
1.1 The role of D type cyclins in keratinocyte cell cycle regulation  
 
Quiescent (G0 phase) basal (keratin1/keratin10 negative) K1/K10- keratinocytes 
freshly isolated from human skin express D1, but not D2 type cyclin, when they almost 
synchronously traverse from G0-G1 into an initial cell cycle as a result of a wound response 
to disaggregation and in vitro culturing. As keratinocytes enter subsequent cell cycles, D1 
expression disappears and D2 cyclin becomes clearly detectable. The differential expression 
of cyclin D1 and D2 in keratinocytes suggests specific functions for D type cyclins and 
provides direct evidence that the G0-G1-S progression of quiescent keratinocytes is distinct 
from the G1-S traverse of already cycling cells. Recently it was shown that cyclin D1-
mediated proliferation predominantly occurs in the immediate progeny of the stem-cell-rich 
bulge cells in human hair follicle, indicating that cyclin D1 may be important for cells to exit 
the stem cell compartment. On the other hand, cyclin D3 was reported to accumulate to high 
levels in the stratified squamous epithelial layers of postreplicative, differentiating cells in 
mice. 
The HaCaT keratinocyte cell line is a spontaneously transformed human epithelial cell 
line derived from a histologically normal skin specimen. Despite the altered and unlimited 
growth potential, HaCaT cells, similarly to normal keratinocytes, form an orderly structured 
and differentiated epidermal tissue, when transplanted onto nude mice. They exhibit a number 
of chromosomal aberrations characteristic for skin SCCs but lack the gain of 11q, are non-
tumorigenic, and still posess the ability to form a normally differentiated epidermis-like 
epithelium under appropriate conditions. HaCaT cells are commonly used for gene 
transfection studies or as a model system to study hyperproliferative skin diseases such as 
psoriasis, or to study cancer development.  
Previously it has been described that cyclin D1 overexpression alters the proliferation 
and differentiation behavior of HaCaT cells in organotypic co-cultures, while the epithelia 
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appeared undifferentiated, lacking morphologically distinct cell layers and signs of 
cornification. In HaCaT epithelia as in the epidermis in situ proliferation is restricted to the 
basal layer. In the cyclin D1 overexpressed HaCaT cell-organotypic co-culture BrdU-positive 
nuclei were only seen in the basal layer. 
 
1.2 Functions of D type cyclins beside cell cycle regulation  
 
Data suggest that D type cyclins are involved in a large complexity of networks of 
interactions and play some new roles besides acting as Cdk partners. Cyclin D1 regulates 
cellular metabolism, fat cell differentiation and cellular migration, cyclin D2 plays a role in 
macrophage activation  and spermatogonial differentiation, while cyclin D3 has a role in the 
promotion and maintenance of the terminally differentiated state of some cell types. 
Knockout experiments in murine models also suggest that the function of different D 
cyclin subtypes is not entirely redundant. Knocking out the different D cyclin isotypes in mice 
results in different phenotypes: „Cyclin D1 only” mice develop severe megaloblastic anaemia, 
„cyclin D2 only” mice present neurological abnormalities, and „cyclin D3 only” mice lack 
normal cerebella. Mice lacking cyclin D1 display hypoplastic retinas, underdeveloped 
mammary glands and present developmental neurological abnormalities. At the same time 
knock in strain of mice expressing cyclin D2 in place of D1 shows nearly normal 
development of retinas and mammary glands, and D2 can partially replace the function of 
cyclin D1 in neurological development.  
In HeLa cells specific knockdown of cyclin D3 by small interfering RNA results in a 
delayed progression through G2 phase and mitosis. HeLa cells exit mitosis with a resultant 
increase in cells with multiple or micronuclei because chromosomes fail to migrate to the 
metaphase plate. These data indicate an important function for cyclin D3 activity in the S/G2 
phase. In bronchial epithelial (BEAS) cells the siRNA targeting of each D type cyclin caused 
growth suppression. Multiple siRNA transfection targeting all the D type cyclins resulted in 
cooperative growth suppression in these cells indicating that functional interactions are 
needed for efficient cell growth in BEAS cells. 
 
 
1.3 Epidermal hyperproliferation and abnormal differentiation in psoriasis  
 
Psoriasis is considered to be a multifactorial inflammatory skin disease with distinct 
hyperproliferation of the normally quiescent basal keratinocyte population which contains the 
keratinocyte stem cells. Although, there is strong evidence that dysregulated inflammation 
plays a pivotal role in disease development and maintenance, data indicate that epidermal 
abnormalities contribute to disease susceptibility. Fibronectin as a prominent component of 
extracellular matrix has been shown to increase cell cycle entry among uninvolved but not 
normal keratinocytes. Concordantly, α5 integrin the receptor of fibronectin, but not α2 or α3, 
is overexpressed in the in vivo non-lesional psoriatic epidermis. The role of abnormal α5 
integrin expression in psoriasis pathogenesis is further supported by the fact that mice with 
forced suprabasal integrin expression exhibit epidermal hyperproliferation, perturbed 
keratinocyte differentiation, and skin inflammation. 
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1.3 The role of D3 vitamin in the therapy of psoriasis  
 
1,25-Dihydroxyvitamin D3 and its analogs represent candidate compounds for 
treatment of hyperproliferative diseases including psoriasis and diverse types of cancer. A 
major advantage of these reagents lies in the ability not only to halt proliferation, but also to 
induce differentiation or cell death. The cell cycle arrest induced by 1,25-VD3 and its analogs 
has been investigated in tumor cells of leukemic, prostate, pancreatic and breast cancer origin, 
as well as in normal keratinocytes. The consensus view emerging from these studies identifies 
G1 phase as the major target of the observed cell cycle blockade. A series of studies found 
that D type cyclins bind several transcription factors and regulate their activity. Cyclin D1 
could form a specific complex with estrogen receptor (ER) and activate the transcription 
activity of the receptor in a Cdk4 and ligand independent manner. Cyclin D2 and D3 were 
also found to associate with the estrogen receptor to a lesser extent and showed a less 
pronounced effect than cyclin D1 on ER. Vitamin D receptor (VDR) is a member of the 
superfamily of nuclear receptors for steroid hormones and Yian et al. showed that cyclin D3 
interacts with VDR and regulates its transcription activity. 
 
 
2. Aims 
 
• to characterize the expression pattern of D-type cyclins in synchronized HaCaT 
keratinocytes. 
• to investigate the funtions of D-type cyclins in keratinocytes 
• to compare the expression of D-type cyclins in healthy, psoriatic lesional and non-
lesional epidermis. 
• to determine whether the proliferation-related α5 integrin regulates the expression of 
cyclin D1 
• to assess the effect of D3 vitamin on the expression of D-type cyclins 
 
 
3. Methods 
3.1 Cell cultures 
HaCaT cells, the spontaneously immortalized non-tumorigenic human keratinocyte-derived 
cell line, (kindly provided by Dr N.E. Fusening, Heidelberg, Germany) were cultured in a 
high-glucose Dulbecco’s modified Eagle’ medium supplemented with 10% fetal bovine 
serum, L-glutamine, antibiotics (penicillin and streptomycin) and an antimycotic 
(amphotericin B).  
3.2 Human tissue samples 
Shave biopsies were taken from uninvolved and involved skin of psoriatic patients from the 
buttock area. Control skin biopsies from the breast and the stomach area were obtained from 
healthy individuals undergoing plastic surgery. After removal of the subcutaneous tissue, skin 
biopsies were incubated overnight at 4°C in Dispase solution (grade II; Roche Diagnostics, 
Mannheim, Germany). On the following day, the epidermis was separated from the dermis. 
All tissue samples were taken with the patient’s informed consent and the approval of the 
local ethics committee. The study was conducted according to the Declaration of Helsinki 
Principles. 
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3.3 Synchronization procedure 
HaCaT keratinocytes were synchronized and cultured as described previously (Pivarcsi et al., 
2001). Samples were collected 0, 12, 24, 36, 48, 72, 96 and 168h following the end of the 
synchronization process. 
3.4 Quantitative reverse transcription (RT)-PCR 
For quantitative real time RT-PCR, 1 µg purified total RNA was reverse transcribed with the 
iScript cDNA Synthesis Kit according to the manufacturer’s instructions. After RT, 
amplification reactions were carried out with an iCycler machine using the appropriate primer 
pairs and probes. To detect 18S rRNA (as endogenous control) we used sequence-specific 
TaqMan probes. The amount of cDNA was calculated on the basis of the threshold cycle 
value, and was standardized by the amount of housekeeping gene (18S rRNA). 
3.5 Flow cytometry 
The epidermis was separated from the dermis as described previously. Epidermal and HaCaT 
keratinocyte suspensions were prepared using trypsin (0.25% for epidermal and 0.025% for 
HaCaT cells). Cells were fixed in -20°C cold 70% ethanol (Reanal, Budapest, Hungary) and 
kept at -20°C for at least overnight before staining. The following monoclonal antibodies 
were used: Purified Mouse Anti-Human Cyclin D1, Purified Mouse Anti-Human Cyclin D2 
and Purified Mouse Anti-Human Cyclin D3 at 1:200 dilution, all from BD Pharmingen (San 
Diego, CA), mouse IgG1, mouse IgG2a and mouse IgG2b at the same concentrations served 
as isotype controls (all from Sigma, Steinheim, Germany). Secondary antibodies were anti-
mouse IgG1, IgG2a and IgG2b coupled to fluorescein isothyonate (FITC), used at 1:50 and 
mouse IgG2b at 1:500 dilutions all from BD Pharmingen (San Diego, CA). Analysis was 
carried out using a FACScalibur flow cytometer (Becton Dickinson, San Jose, CA) and 
CellQuest software (Beckton Dickinson). Results were expressed either as the geometric 
mean fluorescence intensity (GeoMean) calculated by substraction (GeoMean of the antigen 
specific antibodies stained cells - GeoMean of isotype-matched control antibodies stained 
cells), or as % positive cells. 
3.6 Gene silencing 
HaCaT keratinocytes were contact inhibited for 1 day and serum starved for 5 days. Cells 
were then harvested and nucleofected with cyclin D1, D2 and D3 siRNAs by NucleofectorTM 
II (Amaxa Biosystems, Koeln, Germany) using V-Kit optimized for HaCaT keratinocytes 
(VCA-1003, Amaxa Biosystems, Koeln, Germany) in suspensions and then plated into 12 
well tissue culture plates and cultured in antibiotic free medium containing 10% fetal bovine 
serum and incubated at 37°C. Cyclin D1 siRNA (sc 29286), Cyclin D3 siRNA (sc 35136) 
siControl RNA (sc 36869) all from Santa Cruz Biotechnology, INC (Santa Cruz, California) 
and CCND 2 (Cyclin D2) SMARTpool siRNA (M 003211) from Upstate (Billerica, USA) 
were used following the instructions of the manufacturer. Samples were taken at 24, 48 and 
72 h following the passage of the cells. Control siRNA is a non-targeting 25 nt siRNA 
designed as a transfection control. Total RNA was isolated using TRIzol
TM
 reagent 
(Invitrogen, Carlsbad CA, USA). Real-Time RT-PCR was carried out as described above to 
quantify the mRNA expression of cyclin D1, D2 and D3. The transfection efficacy was 
detected using a plasmid encoding the enhanced green fluorescent protein eGFP (Amaxa 
Biosystems, Koeln, Germany) 48 hours post transfection by flow cytometry. 
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3.7 MTT (Thiazolyl Blue Tetrazolium Bromide) assay 
HaCaT keratinocytes were contact inhibited for 1 day and serum starved for 5 days. Cells 
were then trypsinized and nucleofected in cell suspension with cyclin D1 siRNA. HaCaT 
keratinocytes were seeded into wells of 96-well plates directly after transfection at a density 
of 5 x 10
3
 cells/well and grown in 200 µl complete high glucose DMEM medium for 24, 48, 
72, 96, and 168 hours. MTT assays were carried out as described previously (Sonkoly et al., 
2005). 
3.8 Immunohistochemical staining 
Formalin-fixed, paraffin embedded tissue sections were dewaxed. Slides were placed in a 
slide rack and immersed into 500 ml of 10 mM citric acid buffer (pH 6.0). After incubation in 
a microwave oven for 30 min at 700 W, during which the incubation solution boiled for about 
25 min, slides were rinsed with TBST (Tris buffered saline, Sigma, Steinheim, Germany, 
containing 0.1% Triton-X, Reanal, Budapest, Hungary) for 15 min. Non-specific staining was 
prevented by pre-incubation with 0.5% bovine serum albumin diluted in TBST (Tris buffered 
saline, Sigma, Steinheim, Germany, containing 0.1% Triton-X, Reanal, Budapest, Hungary). 
Cells were then incubated overnight at 4°C in a humid chamber with the primary antibodies. 
Purified monoclonal antibodies to cyclin D1, cyclin D3 (NeoMarkers, Fremont, CA) and 
cyclin D2 (Fitzgerald Industries Int., Inc., Concord MA, USA) were applied at 1:200, 1:25 
and 1:2 dilutions respectively, rabbit IgG (NeoMarkers, Fremont, CA), mouse IgG1 and 
mouse IgG2a (Sigma, Steinheim, Germany) were used for isotype control stainings. Slides 
were then incubated with a biotinylated secondary antibody (anti-rabbit IgG for cyclin D1, 
anti-mouse IgG for cyclin D2 and D3 all at 3.3 µg/ml concentration), followed by incubation 
with horse radish peroxidase-conjugated streptavidin (Vectastain ABC Kit, Vector, 
Burlingame, USA), and finally peroxidase activity was detected using 3,3 amino-9 
ethylcarbazole (AEC, Sigma) as a substrate. Slides were counterstained with hematoxylin 
(Sigma, Steinheim, Germany). Tissue staining was visualized using a Zeiss Axio Imager 
microscope and photographed using a PixeLINK digital camera. 
 
3.9  α5 integrin blocking assay 
1x10
6
 synchronized HaCaT keratinocytes were seeded into 25 cm
2
 cell culture flasks 
(Sarstedt, Germany). 5 hours after seeding, when the cells already attached to the surface of 
the culture flask, an α5 integrin neutralizing purified mouse anti-human monoclonal antibody 
(CD49e, no azide-low endotoxin, BD Pharmingen, San Diego, USA) was added to the cells at 
20 µg/ml final concentration. Mouse IgG1 (BD Pharmingen, San Diego, USA) at identical 
concentration was used for isotype control. HaCaT keratinocytes were incubated with the 
antibody for 7 hours. Samples were collected before (0 hours) and 12 hours following the 
seeding of the cells. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad CA, 
USA) following the instructions of the manufacturer. Samples were analyzed by real-time 
RT-PCR to quantify the mRNA expression of cyclin D1, D2 and D3. 
 
3.10 Fluorescent immunocytochemistry 
HaCaT keratinocytes were contact inhibited for 1 day and serum starved for 5 days. Cells 
were then trypsinized and nucleofected in cell suspension with cyclin D1, D2 and D3 siRNAs. 
HaCaT keratinocytes were seeded onto 8 Chamber Polystyrene Vessel Tissue Culture Treated 
Glass Slides (Falcon CultureSlide, Becton Dickinson Labware Europe, France). Cultured cells 
on slides were fixed in 2% paraformaldehyde. Non specific staining was prevented by pre 
incubation with 0.5% bovine serum albumin diluted in TBST (Tris buffered saline, Sigma, 
Steinheim, Germany, containing 0.1% Triton X, Reanal, Budapest, Hungary). Cells were then 
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incubated overnight at 4°C in a humid chamber with the primary antibodies. Purified 
monoclonal antibodies to cyclin D1, cyclin D3 (NeoMarkers, Fremont, CA) and cyclin D2 
(Fitzgerald Industries Int., Inc., Concord MA, USA) were applied at 1:200, 1:25 and 1:1 
dilutions respectively, rabbit IgG (NeoMarkers, Fremont, CA), mouse IgG1 and mouse IgG2a 
(Sigma, Steinheim, Germany) were used for isotype control stainings. Slides were then 
incubated with fluorescent conjugated secondary antibodies (Alexa Fluor 488 goat anti rabbit 
IgG for cyclin D1 and Alexa Fluor 647 goat anti mouse IgG for cyclin D2 and D3, all at 2.5 
µg/ml final concentration), followed by incubation with 4,6 Diamidino 2 phenylindole 
dihydrochloride (DAPI, Sigma, Steinheim, Germany at 1 µg/ml final concentration). Cell 
staining was visualized using a Zeiss Axio Imager microscope and photographed using a 
PixelFLY (PCO) digital camera. 
 
3.10 Apo 2.7-PE staining 
HaCaT keratinocytes were contact inhibited for 1 day and serum starved for 5 days. Cells were 
then harvested and nucleofected with cyclin D1, D2 and D3 siRNA in suspensions and then 
plated into 12 well tissue culture plates and cultured in antibiotic free medium containing 10% 
fetal bovine serum. Cells were harvested by trypsinization and washed in PBS. Cell density 
was adjusted to 1 x 10
6
 cells/ml. The pellet was resuspended in 100 µl cold 4°C 100 µg/ml 
digitonin in PBSF (PBS with 2.5% FBS). Cells were washed in 4°C PBSF and the pellet was 
resuspended in 20 µl of Apo2.7 PE (Coulter, Immunotech, Marseille, France) and 80 µl of 
PBSF and incubated for 15 min in the dark at RT. After washing, cells were resuspended in 1 
ml of PBSF. Analysis was carried out using a FACScalibur flow cytometer (Becton Dickinson, 
San Jose, CA) and CellQuest software (Beckton Dickinson). 
 
3.12 Propidium iodide DNA staining 
HaCaT keratinocytes were harvested, nucleofected and cultured as described above. Cell 
density was adjusted to 1 x 10
6
 cells/ml. The pellet was resuspended in 70% cold ( 20°C) 
ethanol and fixed for at least 24h at 20°C. After fixation, cells were centrifuged and washed in 
PBS. Cells were then resuspended in 500 µl PI/RNase staining buffer (containing 50 µg/ml PI 
and 100 U/ml RNase A from BD) and left for 30 min at room temperature. The samples were 
analysed using a FacsCalibur machine (Becton Dickinson) and evaluated by Modfit software 
(Verity Software House, Topsham, ME). 
 
3.13 Immunocytochemistry 
HaCaT keratinocytes were treated, fixed and stained with primary antibodies as described 
above. Purified monoclonal antibodies to cytokeratin 1 and 10 and integrin alpha 5 (Abcam, 
Cambridge, UK) were applied at 1:800 and 1:500 dilutions respectively, mouse IgG1 and 
mouse IgG2b (Sigma, Steinheim, Germany) were used for isotype control stainings. Slides 
were then incubated with biotinylated secondary antibody (anti mouse IgG for both cytokeratin 
1 and 10 and alpha 5 integrin were applied, all at 3.3 µg/ml concentration) for 1h at room 
temperature, followed by incubation with horse radish peroxidase conjugated streptavidin for 
1h at room temperature (Vectastain ABC Kit, Vector, Burlingame, USA), and finally 
peroxidase activity was detected using 3,3 amino 9 ethylcarbazole (AEC, Sigma) as a 
substrate. Slides were counterstained with hematoxylin (Sigma, Steinheim, Germany). Tissue 
staining was visualized using a Zeiss Axio Imager microscope and photographed using a 
PixeLINK digital camera. 
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3.14 1,25-dihydroxyvitamin D3 treatment of the cells  
Synchronized HaCaT keratinocytes were treated with 1,25-Dihydroxyvitamin D3 at a 10
-7
 M 
concentration. Control cells were treated with the vehicle – ethanol at identical concentration. 
Samples were collected 42 hours after D3 vitamin treatment, at the time when cells were 48 
hours after release from cell quiescence. 
3.15 Data presentation  
Gene expression results were expressed as fold increases over control values. Data were 
presented as mean +/- Standard Deviation (SD) for n experiments. Flow cytometry data were 
expressed either as % over isotype values or as the geometric mean fluorescence intensity 
(GeoMean) calculated by substraction of the GeoMean of isotype stained cells from the 
GeoMean of the specific antibody stained cells. Data were compared using one-way analysis 
of variance (ANOVA) followed by Dunnett’s post hoc test to determine statistical differences 
after multiple comparisons (SPSS, SPSS Inc., Chichago, IL). Data from the α5 integrin 
blocking assay were compared using the Mann-Whitney U test. Probability values of less than 
0.05 for both parametric and non-parametric tests were considered significant. 
 
 
4. Results and Discussion 
 
4.1 D type cyclins: functional redundancy or unique role of the different 
isotypes in human keratinocyte proliferation and differentiation  
 
D-type cyclins are rate limiting factors of the G1 progression. Several reports suggest 
that D-type cyclins have non-overlapping functions in cell cycle regulation in specific cell 
types. In normal human keratinocyte cultures, when quiescent (G0) K1/K10
-
 keratinocytes 
traverse into the first cell cycle, they express cyclin D1, but not D2, as determined by 
antibody staining and flow cytometric analysis. As keratinocytes go into subsequent cell 
cycles in the in vitro culture, D1 protein expression disappears and cyclin D2 expression 
becomes clearly detectable. Corresponding with the lack of protein expression, cyclin D1 
mRNA is not detectable 24 hours after plating, but it is clearly present as cells go into the first 
round of cell cycle (3-4 day cultures) and decreases in the subsequent cell cycles. In normal 
human skin a great number of keratinocytes express cyclin D1 in the basal and immediately 
suprabasal layer when they are induced to hyperproliferate 72 hours after a 2 MED UVB 
irradiation. 
We obtained similar results in immortalized keratinocytes (HaCaT) both at the mRNA 
and protein level. The highest level of cyclin D1 expression was detected 24 hours after 
release from cell quiescence when cells started to proliferate. Cyclin D2 and D3 also showed 
low levels of expressions in quiescent cells (0 hours). Cyclin D2 and D3 mRNA and protein 
levels gradually increased in the cells after release from cell quiescence, but their peak 
expression occurred at 48-72 hours in already proliferating cells. Both cyclin D2 and cyclin 
D3 expressions showed maximum levels at 48 and 72 hours. As cell cultures became 
confluent mRNA levels for all cyclins have decreased. 
 Although HaCaT keratinocytes showed differential expression in the synchronized 
culture, cyclin D1 gene-specific silencing had no effect on the proliferation and morphology 
of HaCaT keratinocytes during the interval between cellular quiescence and intense 
proliferation after release from quiescence. We did not detect a compensatory increase in 
silenced cells for the remaining D-type cyclin mRNAs. It has been shown that the lack of 
cyclin D1 expression does result in significant reduction in mouse skin and mammary tumor 
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development. However, complete elimination of tumor development was not observed in 
these models, suggesting that other cyclin/cdk complexes may partially compensate for the 
loss of cyclin D1 function. It is also known that in knock-in mice expressing cyclin D2 in 
place of cyclin D1, cyclin D2 can replace cyclin D1’s functions. Our results also indicate that 
D2 and D3 cyclins could substitute for D1 in driving keratinocyte cell cycle.  
Similar to D1 cyclin silencing, knocking down cyclin D2 and D3 alone had no effect 
on the proliferation and morphology of HaCaT keratinocytes. Silencing of the individual 
D-type cyclins did not result in a compensatory increase of the other two D- type cyclins in 
the cells. In mice, there is evidence that cyclin D2 and D3 can compensate for each other in 
driving the cell cycle of B lymphocytes. In human bronchial epithelial (HBE) cells the 
independent targeting of D-type cyclins using small interfering RNAs, however results in cell 
growth suppression. The fact that knocking down individual D cyclins had no effect in 
HaCaT cell proliferation and morphology in our experiments may be explained by the fact 
that  these cells are not normal, but immortalized keratinocytes. The requirement for 
individual D-type cyclin functions in cell cycle regulation may vary among different cell 
types. There is evidence in mammalian embryonic fibroblasts that even normal cell cycles can 
take place without cyclin D CDK4/6 complex, in these cells cyclin E CDK2 alone is able to 
phosphorylate and inactivate pRb, activate E2F, and induce DNA synthesis. 
Contrary to the single knockdown experiments, double and triple silencing of D- type 
cyclins in HaCaT keratinocytes resulted in the formation of large multinucleated cells, S 
phase arrest and moderate growth suppression. Similar to the single cyclin silencing, no 
compensatory increase was detected in these cells for the remaining D- type cyclins. 
Interestingly, growth arrest and the formation of multinucleated cells were similar in all 
double silenced as well as in the triple silenced cultures. In HBE cells dual knockdown of 
D-type cyclins also resulted in growth suppression, however double or triple silencing of 
D-type cyclins had no effect on cell morphology. Similar to our observation in HaCaT 
keratinocytes no compensatory overexpression of the remaining D-type cyclins was observed 
in HBE cells. It has been also reported that inhibition of cyclin D3 expression by UV 
irradiation blocked HeLa and A2058 cells in G2 phase indicating that cyclin D3 activity was 
necessary for cell cycle progression through G2 phase into mitosis. Small interfering RNA 
knockdown of cyclin D3 delayed the progression through G2 phase in HeLa cells, these cells 
failed to undergo cytokinesis correctly, showing an aberrant mitotic phenotype characterized 
by lagging chromosomes that formed micronuclei after mitotic exit. We have also 
investigated some molecular aspects of cell growth and differentiation in our multinucleated 
HaCaT cells. It has been shown that in continously growing HaCaT keratinocytes the 
expression of α5 integrin and K1/K10 was related to cell proliferation and differentiation. 
Here we demonstrated that triple silenced multinucleated aberrant cells revealed no difference 
in K1/K10 and α5 integrin expression compared to the control cells, suggesting that the 
morphological and proliferative changes, that occur due to triple silencing of D cyclins, did 
not influence the α5 integrin pathway and did not affect K1/K10 expression.  
These data indicate that in some cells the suppression or inhibition of a single D- type 
cyclin is sufficient to affect cell proliferation, while in others, such as our immortalized, 
hyperproliferative HaCaT cells, double or triple silencing of D-type cyclins must be applied 
for inducing cell proliferation and/or morphological changes. Interestingly, the combined 
D-type cyclin mRNA interference did not result in G0/G1 S block, but in G2/M block in the 
cells, as indicated by elevated S fractions in the cultures. Our observation is similar to the 
G2/M block that has been reported in HeLa cells by cyclin D3 silencing. In HeLa cells the 
aberrant mitosis was due to the failure in chromosome migration to the metaphase plate. 
These cells showed the same morphological characteristics (cells with multiple or 
micronuclei) as HaCaT cells in our experiments. In the cyclin D3 silenced HeLa cells lagging 
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chromosomes were visualized which often decorated the astral side of the spindle 
microtubules. Protein expressions of the chromosomal passengers were a little lower or 
unaffected: survivin and borealin showed a slight decrease and the level of Aurora B was 
unchanged indicating, that these proteins were functioning normally. While in HeLa cells an 
intact cyclin D3 function seems critical for normal G2/M progression, in HaCaT keratinocytes 
the lack of D3 function alone does not lead to G2/M block. The omission of at least two 
D-type cyclins was required for cell cycle disturbance in the G2/M phase. Interestingly we 
have not seen changes in G0/G1-S progression in our cells even when cells lacked all three 
D-type cyclins, indicating that similar to mammalian embryonic fibroblasts, normal G0/G1-S 
progress can take place without D-type cyclins in HaCaT keratinocytes. In our experimental 
setup we have not been able to uncover the functional differences between the different 
D-type cyclins.  
We conclude that the regulatory functions of D-type cyclins in keratinocytes are not 
completely redundant. Although knocking down cyclin D1,D2 and D3 alone in quiescent 
keratinocytes does not result in immediate changes in cell morphology and proliferation, the 
differential expression of these cyclins in cultured keratinocytes suggest that they may have 
other specific functions beside driving the cell cycle. Furthermore, D-type cyclins do not seem 
essential for G0/G1 S progression in HaCaT keratinocytes, but at least two of them have to 
function for normal G2/M transition.  
 
4.2 D type cyclins: participants in the pathogenesis of psoriasis and new 
therapeutical targets  
 
Although not yet characterized, beside cell cycle regulation D-type cyclins have 
multiple functions, as indicated by increasing data. The fact that different cell types 
differentially express D-type cyclins also supports this hypothesis. Cyclin D3 is ubiquitously 
expressed in seventy different human cultured cell types while D1 and D2 are not. 
Complementary analyses of human and mouse tissues at different stages of foetal and 
postnatal development revealed a correlation between cyclin D3 abundance and mature-
differentiated phenotypes, indicating a possible role for cyclin D3 in the induction and 
maintenance of terminal differentiation. In previous work using the same synchronized 
HaCaT keratinocyte model we found that the highly proliferating, cyclin D1 expressing, 
immediately postquiescent cells downregulate the early differentiation markers K1/10 at the 
mRNA levels. Overexpressed cyclin D1 in HaCaT keratinocytes results in deregulation of 
tissue architecture with altered localization and impaired differentiation, these cells lack 
terminal differentiation and exhibit a more autonomous growth, even form keratoacanthoma-
like tumors in vivo.  
HaCaT cells, although immortalized and genetically abnormal, are considered to be a 
good model for human keratinocytes. With their high proliferative potential, they especially 
resemble keratinocytes found in the skin disease psoriasis. Psoriasis can be characterized with 
an excessive basal cell proliferation and perturbed keratinocyte differentiation, which are 
regarded as central pathologic features of the disease. Because hyperproliferation in the 
psoriatic epidermis is due to activation of the normally quiescent cells in the β1 integrin
+
 
K1/K10
-
 basal cell compartment, we expected the expression of D1 type cyclin to be 
increased both at the mRNA and protein levels in psoriatic epidermis. Contrary to our 
expectation, we detected a significant increase in cyclin D2 and D3 mRNA expression in 
chronic plaques of lesional psoriatic epidermis compared to normal epidermis, but the 
expression of cyclin D1 mRNA showed no difference. By flow cytometric analysis, the 
percentage of cells expressing D1, D2 and D3 cyclins was similar in the psoriatic epidermis as 
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in the normal and the non-lesional epidermis. The percentage of D1 and D2 protein 
expressing cells was low relative to the percentage of D3 protein expressing cells in all 
samples. This result is similar to our previous observation showing that the increased number 
of cycling keratinocytes in the psoriatic β1 integrin
+
 K1/K10
-
 basal compartment did not 
result in an overall increase in the size of this cell compartment, indicating that the proportion 
of β1 integrin
+
 K1/K10
-
 cells that self-renew (to β1 integrin K1/K10
-
 cells) is the same in 
psoriatic epidermis as it is in normal epidermis, and that excess cells are committed toward 
differentiation.  
Immunostainig of tissue sections revealed that the psoriatic lesional epidermis 
contained more cells in absolute numbers that showed distinct nuclear and some cytoplasmic 
expression of cyclin D1 protein than the normal and psoriatic non-lesional epidermis where 
we could detect only nuclear staining in a few basal layer cells. Xu et al. found that cyclin D1, 
D2 and D3 were not detectable by immunohistochemistry in the rapidly proliferating hair-
producing cells of the anagen bulb while these cells were strongly positive for Ki-67 and 
retinoblastoma protein. Contrary to these data, we found that cyclin D3 protein was expressed 
in the cytoplasm and nucleus of the suprabasal cells in the hair follicles and the proportion of 
positively stained cells seemed to be similar in the psoriatic lesional, non-lesional and normal 
epidermis. We used different antibodies for flow cytometry and immunohistochemistry 
because neither of the antibodies were suitable for both methods. We could not detect cyclin 
D2 in normal and lesional psoriatic epidermis by immunohistochemistry although some skin 
tumors (squamous cell carcinoma and melanoma) that we stained with the same antibody 
showed clear positive immunostaining of cyclin D2.  
Beside transcriptional and posttranscriptional regulation, the expressions of D- type 
cyclins are regulated by targeted degradation via the ubiquitine pathway. The fact that there 
are more cyclin D1 positive cells in the stable psoriatic lesion localized both in the basal as 
well as in the immediate suprabasal compartment of the epidermis, at the same time no 
increase in D1 mRNA can be detected in the psoriatic samples, indicate a possible 
dysfunction in the degradation of cyclin D1 in this disease, that could be partially responsible 
for keratinocyte hyperproliferation and abnormal differentiation of the basal keratinocytes. It 
is possible that by retaining cyclin D1 expression, the highly proliferative β1 integrin
+
 
K1/K10
-
 basal compartment keratinocytes in the psoriatic epidermis protect their stem cell 
potential. Indeed, primary cultured keratinocytes with induced cyclin D1 transgene expression 
show resistance to calcium-induced terminal differentiation and continue to replicate in vitro. 
The significant increase in the relative expressions of cyclin D2 and D3 mRNAs in the 
psoriatic lesional epidermis with no change in protein expressions indicates 
posttranscriptional dysregulation of these cyclins in psoriatic keratinocytes.  
It is well documented that in the skin, as in other tissues, keratinocyte integrins are 
important regulatory molecules in epidermal homeostasis. The main receptor of fibronectin, 
α5 integrin is abnormally overexpressed in uninvolved keratinocytes of the in vivo psoriatic 
epidermis  and the A domain of fibronectin (EDA
+
) is present at the basement membrane zone 
of uninvolved psoriatic skin while absent in normal control skin. Upon in vitro activation 
there is enhanced EDA
+
 fibronectin expression in psoriatic uninvolved keratinocytes 
compared to normal cells. The finding that α5 integrin regulates cyclin D1 mRNA expression 
in quiescent HaCaT keratinocytes indicate that the abnormally active fibronectin-α5 integrin 
ligand-receptor induced pathway in the psoriatic non-lesional keratinocytes could contribute 
to keratinocyte hyperproliferation in psoriasis. That cyclin D1 expression is dependent on 
intact α5 integrin function has also been indicated in the keratinocyte derived SCC12 cells, in 
which binding of the ganglioside GT1b to α5 integrin inhibited the expression of cyclin D1. 
We have also found that in our HaCaT keratinocyte model system the antipsoriatic 
1,25-Dihydroxyvitamin D3 had an effect on all D-type cyclin mRNA expression, indicating 
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that D-type cyclins could be the target of the 1,25-Dihydroxyvitamin D3 therapeutic effect  in 
psoriasis.  
 
 
 
5. Summary 
 
• We have demonstrated that the G0-G1/S phase of HaCaT keratinocyte cell cycle is 
characterized by D1-type cyclin expression, while during the repeated rapid turnover 
of highly proliferating cells, the expression of cyclin D2 and D3 dominates.  
• We have showen that in HaCaT keratinocytes knocking down cyclin D1, D2 or D3 
mRNA alone results in no change of cell proliferation and morphology, while those 
cells that were nucleofected with two or three D cyclin siRNAs at the same time, 
formed large multinucleated cells after silencing leading to S phase arrest and 
moderate growth suppression.  
• By using immunohistochemistry we have shown that increased numbers of cyclin D1 
expressing keratinocytes are located in the basal layers of the lesional psoriatic 
epidermis compared to both normal and non-lesional epidermis.  
• We have also detected a significant increase in D2 and D3 cyclin mRNA expression in 
psoriatic epidermis compared to normal epidermis with no difference in protein 
expressions.  
• We have demonstrated that blocking α5 integrin function by a neutralizing antibody in 
HaCaT keratinocytes down-regulated the expression of D1 cyclin mRNA without 
affecting the expressions of cyclin D2 and D3.  
• We revealed that the antipsoriatic 1,25-Dihydroxyvitamin D3 had an effect on all D 
type cyclin mRNA expression in HaCaT keratinocytes. 
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